Shandong Xinhua Pharmaceutical Company Limited

符号: 000756.SZ

SHZ

16.15

CNY

今天的市场价格

22.4147
市盈率
2.9139
PEG比率
8.86B
MRK市值
0.01%
DIV收益率

Shandong Xinhua Pharmaceutical Company Limited (000756-SZ) 财务报表

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Shandong Xinhua Pharmaceutical Company Limited (000756.SZ). 的默认数据。公司收入显示 2901.861 M 的平均值，即 0.101 % 增长率。整个期间的平均毛利润为 716.517 M，即 0.104 %. 平均毛利率为 0.233 %. 公司去年的净收入增长率为 0.208 %，等于 0.127 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Shandong Xinhua Pharmaceutical Company Limited 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.011. 在流动资产领域，000756.SZ 的报告货币为3314.334. 这些资产中的很大一部分，即 918.334 是现金和短期投资。与去年的数据相比，该部分的变化率为-0.207%. 公司的长期投资虽然不是其重点，但以报告货币计算的275.278（如果有的话）为275.278。这表明与上一报告期相比，-4.264% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 799.4. 这一数字表明，0.354% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 4553.104. 这方面的年同比变化率为 0.103%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为1017.112，存货估值为 1312.98，商誉估值为 0（如有. 无形资产总额（如果有）按 494.94 估值. 应付账款和短期债务分别为 666.41 和 1073.18. 债务总额为1874.16，债务净额为 955.82. 其他流动负债为 597.27，加上总负债 3457.92. 最后，如果存在推荐股票，则其估值为 0.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
balance-sheet.row.cash-and-short-term-investments	3643.84	918.3	1158.7	744.7	855.8	690.5	778.4	731.1	561.3	476.3	328.8	380.7	422.1	299.2	404.1	401.9	238.1	228.2	162.5	363.2	396.5	445.2	503.5	617	279.2	289.6	261.7	228.2	306.5	8.4	19.5
balance-sheet.row.short-term-investments	-137.64	0	-48.4	-56.3	-61.9	-72.8	-69.4	0	-75.6	-78.9	0	0	0	0	0	0	0	15.9	0	0	58.6	31.2	0	0	0	0	261.6	0	0	0	0
balance-sheet.row.net-receivables	4745.26	1017.1	1035.4	937.2	592.7	504.7	545.3	503.7	526.1	607.7	523.9	476.5	484.8	414.5	352.6	329.6	356.6	355.7	393.4	498.7	494.7	513.3	512.2	484.6	17.1	15.3	8.5	7.8	10.5	22.9	33
balance-sheet.row.inventory	4427.67	1313	1212	1027.5	1124.4	1130.3	951.7	713.2	559.5	546.5	588.9	532	489.7	423.8	401.5	344.2	304.5	286	224.4	274.8	300.3	250.5	220.8	197.6	166.1	179.5	180.3	198.3	184.4	160.2	151.4
balance-sheet.row.other-current-assets	237.57	65.9	50.8	44.6	114.1	102.9	73.7	62	63.6	21.1	20.8	3.7	3.3	3.5	1.3	-15.1	-15.6	-20.6	-41.6	-95.6	-77.7	-104.3	-118	-107.9	299.7	332.3	320.1	271.1	218.6	190.5	266.3
balance-sheet.row.total-current-assets	13054.34	3314.3	3457	2754	2686.9	2428.4	2349.2	2010	1710.6	1651.5	1462.4	1392.9	1399.9	1141	1159.5	1060.7	883.6	849.3	738.6	1041	1113.7	1104.7	1118.4	1191.4	762.1	816.8	770.6	705.4	719.9	382	470.2
balance-sheet.row.property-plant-equipment-net	16128.64	4082.6	4000.5	3765.7	3538.9	3201	2884.4	2587.5	2395.4	2225.8	2153.7	1946.4	1697	1426.5	1125.6	1095.9	1044.1	924.4	864.7	897.6	917.8	830	663.3	520.5	499.7	502.1	464	444.6	423.5	384	330.9
balance-sheet.row.goodwill	0	0	0	0	0	0	0	0	0	0	0	2.7	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	1913.47	494.9	474.1	466.5	449.2	411.6	332.7	323.6	283.3	294.6	313	271	257.9	223.5	228.7	198.5	110.7	96.6	93.3	97.3	72.2	70.4	68.3	69.1	62.3	0	64.5	65.8	67.2	68.2	0
balance-sheet.row.goodwill-and-intangible-assets	1913.47	494.9	474.1	466.5	449.2	411.6	332.7	323.6	283.3	294.6	313	273.7	260.6	223.5	228.7	198.5	110.7	96.6	93.3	97.3	72.2	70.4	68.3	69.1	62.3	0	64.5	65.8	67.2	68.2	0
balance-sheet.row.long-term-investments	1176.32	275.3	287.5	316.5	378.6	369.1	278.7	0	265.1	279.4	0	0	0	0	0	0	0	374.8	0	0	6.2	48.9	0	0	0	0	-260.1	0	0	0	0
balance-sheet.row.tax-assets	153.72	91.6	16	15.2	23.5	26	22.2	21.1	25.6	25.6	25.9	18.7	19.2	16.6	3.4	3	1	9.7	0	0	58.6	31.2	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	393.23	95.6	30.1	14.2	15.9	0	49	331.6	42.8	15.4	290.2	217.7	251.7	196.6	222.3	268.1	122.3	15.9	183.4	171.1	130.1	0.1	55.4	55.8	38.7	65.4	261.6	1.5	1.5	4.7	5.1
balance-sheet.row.total-non-current-assets	19765.37	5040	4808.2	4578.1	4406.1	4007.6	3567	3263.7	3012.2	2840.6	2782.7	2456.5	2228.4	1863.1	1580.1	1565.5	1278.1	1421.4	1141.4	1166	1184.7	980.6	787	645.4	600.6	567.5	529.9	511.9	492.2	456.9	336
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	32819.72	8354.3	8265.1	7332	7093	6436	5916.2	5273.6	4722.8	4492.1	4245.1	3849.4	3628.3	3004.2	2739.6	2626.2	2161.7	2270.7	1880	2207.1	2298.5	2085.4	1905.5	1836.7	1362.7	1384.3	1300.6	1217.4	1212.2	839	806.1
balance-sheet.row.account-payables	3935.84	666.4	1090.1	1066.4	742.9	798.5	889.6	738.3	687.2	596.4	483.3	358.9	396.4	358.2	334.2	284	255.1	184.3	219	353.5	307.8	237.5	116.9	83.5	102	99.1	76.5	88.5	82.1	78.6	50.6
balance-sheet.row.short-term-debt	2671.86	1073.2	835.5	693.3	623	889	841.6	241.5	1254.9	1115.5	838.9	475.7	493.4	475.1	200	124	284.5	206.8	235.2	419	556.3	174.2	340	182.1	259.1	339.4	195.2	150.5	270.3	186.7	124.1
balance-sheet.row.tax-payables	102.71	5	33.7	28.2	23.1	19.2	23.6	12	17.7	16.5	13.2	-3.5	-3.2	-8	-22	-0.2	0.5	-2.7	-0.6	-4	-5.6	-19.5	-22	-7.7	4.6	7.3	20.3	-18.3	-10	12.7	18.8
balance-sheet.row.long-term-debt-total	3207.47	799.4	548.4	350.5	464.5	590.6	522.6	931.5	100	378.2	635.9	888.8	717.6	213.3	275.5	270	0	0	0	0	0	200	0	150	0	3.6	113.9	109.4	105.4	84.4	93.2
Deferred Revenue Non Current	411.66	100.7	118.4	132.2	144.7	141.7	128.3	131.7	118.3	97.9	55.2	0	13.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	490.44	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	636.64	597.3	639.7	45.6	32.7	349	605.2	128.6	72.1	45	39.5	27.3	17.4	19.1	20.6	22.9	6.9	22.4	9.7	11.7	11.1	8.5	6.8	10.6	5.7	63.1	4.6	16.9	13.1	19.1	43.3
balance-sheet.row.total-non-current-liabilities	4086.23	971.9	756.7	1179	1320.6	840	759.6	1203.4	373	557.1	732.2	1026.7	830.9	282.3	335.4	333.9	4.2	57.4	3.6	3.6	3.6	203.6	3.6	153.6	3.6	3.6	113.9	109.4	105.4	84.4	93.2
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	7.07	1.6	2.7	4.3	1.8	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	13681.05	3457.9	3915.2	3680.9	3701.7	3325.5	3119.6	2694.2	2643.5	2508	2333.3	2052.5	1851.3	1254.5	1025	956.2	674.7	554	533.4	862.5	955.6	668.1	523.1	495.9	436.8	493.3	450.7	411.5	500.9	463.5	428.3
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	2706.46	674.7	669.6	627.4	621.9	621.9	621.9	478.4	457.3	457.3	457.3	457.3	457.3	457.3	457.3	457.3	457.3	457.3	457.3	457.3	457.3	457.3	457.3	457.3	427.3	427.3	427.3	427.3	411.8	267.3	267.3
balance-sheet.row.retained-earnings	9120.77	2305.4	1988.1	1709.1	1477.3	1250.6	1043.8	838.3	657.4	552	482.2	435.4	407.1	402.8	357	289.2	210.7	193.5	165.4	167.6	163	236.9	214.5	190.4	166.5	148.9	118.3	87.2	53.8	0	15.6
balance-sheet.row.accumulated-other-comprehensive-income-loss	4793.33	819.2	744.7	647.1	674.3	644.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	1507.66	753.8	724.1	484.4	450.4	451.7	1021.6	1163.3	873.7	874.9	881.1	866.9	872.8	849.8	862.2	887.1	785.2	1015.2	720.6	718.5	719.7	719.1	707.8	692.8	331.9	314.6	304.3	291.3	245.7	108.2	94.9
balance-sheet.row.total-stockholders-equity	18128.21	4553.1	4126.5	3467.9	3223.8	2969	2687.2	2480	1988.4	1884.3	1820.7	1759.5	1737.3	1709.9	1676.5	1633.6	1453.3	1666	1343.3	1343.5	1340	1413.3	1379.7	1340.5	925.7	890.8	849.9	805.8	711.3	375.5	377.8
balance-sheet.row.total-liabilities-and-stockholders-equity	32819.72	8354.3	8265.1	7332	7093	6436	5916.2	5273.6	4722.8	4492.1	4245.1	3849.4	3628.3	3004.2	2739.6	2626.2	2161.7	2270.7	1880	2207.1	2298.5	2085.4	1905.5	1836.7	1362.7	1384.3	1300.6	1217.4	1212.2	839	806.1
balance-sheet.row.minority-interest	889.79	222.6	223.4	183.2	167.5	141.5	109.3	99.4	90.9	99.8	91.2	37.3	39.7	39.8	38	36.3	33.7	50.8	3.3	1.1	2.9	4	2.7	0.3	0.2	0.1	0	0	0	0	0
balance-sheet.row.total-equity	19018	4775.8	4349.9	3651.1	3391.3	3110.5	2796.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	32819.72	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	1038.68	275.3	239.2	260.2	316.6	296.2	209.3	258.1	189.5	200.4	220.6	153.7	182.8	159.4	186.6	231.4	122.3	390.7	66.4	54.1	64.7	80.1	55.3	55.6	38.7	1.7	1.5	0	0	0	0
balance-sheet.row.total-debt	5880.91	1874.2	1383.9	1043.8	1087.5	1479.6	1364.3	1173	1354.9	1493.7	1474.8	1364.4	1211	688.5	475.5	394	284.5	206.8	235.2	419	556.3	374.2	340	332.1	259.1	339.4	309.1	259.8	375.6	271.2	217.3
balance-sheet.row.net-debt	2237.07	955.8	225.1	299.1	231.8	789.2	585.9	441.8	793.5	1017.5	1146.1	983.7	788.9	389.2	71.5	-7.9	46.4	-5.4	72.7	55.8	218.4	-39.8	-163.5	-284.9	-20.1	49.7	309.1	31.6	69.2	262.7	197.9

现金流量表

在 Shandong Xinhua Pharmaceutical Company Limited 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -1.101 的转变。该公司最近通过发行 0 扩大了股本，与上一年相比出现了0.755 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-313274334.000. 与上一年相比， 0.369 发生了变化. 在同一时期，公司记录了 520.25, -8.17 和 -25.72，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-134.94 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 -35.45，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	486.79	496.5	426.3	362.1	347.1	323.1	274.3	221.2	133	94	68.3	38.3	26.3	79.6	102.8	105.9	0	38.1	21.9	3.7	-56.6	42	68.8	81	69.1	63.6	52.8
cash-flows.row.depreciation-and-amortization	5.33	520.3	484.8	434.3	385.4	344.6	302.3	283.5	255.8	228.1	200.8	185.8	159	134.4	126.1	122.3	0.1	105.1	102.8	98	89.7	80.2	73.5	57.4	65.4	61.2	0
cash-flows.row.deferred-income-tax	577.52	6	20	13.7	22.8	13.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	80.43	-1917.3	46.4	4	8.3	8.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-491.34	-876.8	-265.4	-539.6	-362.8	-423.7	-316.7	-143.1	-13.4	-22.1	-63.5	-179.2	-206.3	-198	-112.2	85.4	-0.1	-34	-22.3	48.8	-16.9	-11.8	-109.6	-151.1	8.6	-24	0
cash-flows.row.account-receivables	-423.54	-423.5	-717.3	-751.1	-683.3	-301.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-120.86	-120.9	-200.1	76.2	37.5	-202.9	-263.4	-153.7	-23.8	32.6	-69	-48.1	-66.3	-18.8	-63.9	-39.2	0	-63.1	45.8	25.5	-49.8	-31.8	-23.2	-31.7	12.8	1.9	0
cash-flows.row.account-payables	0	-332.4	632.1	121.6	260.2	66.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	53.07	0	20	13.7	22.8	13.3	-53.3	10.7	10.4	-54.6	5.6	-131.1	-140	-179.2	-48.3	124.6	-0.1	29.1	-68.1	23.4	32.9	20	-86.4	-119.3	-4.2	-26	0
cash-flows.row.other-non-cash-items	-144.29	2044.7	46.1	-15.4	19.3	82.6	84.6	28.3	63.9	48.6	140.7	47.7	58.8	81.1	56.4	31.2	0	11.3	30.9	28.3	43	20.9	9.9	-1	24.4	-50.2	-52.8
cash-flows.row.net-cash-provided-by-operating-activities	487.09	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-321.28	-325.1	-244.8	-249.2	-280.2	-366.5	-386	-261.1	-227.1	-169.1	-260.2	-343	-386.5	-337.6	-217.9	-244.6	-162.3	-87.7	-91.2	-83.5	-141.2	-184	-146.1	-73.8	-47.1	-66.5	-61
cash-flows.row.acquisitions-net	11.27	11.9	45.3	19.8	283.8	369.3	6.5	0	0	0	-102	0	-22	0	0	245.6	164.3	104.4	101.4	96.8	142.3	185.5	0	73.8	47.1	0	0
cash-flows.row.purchases-of-investments	-9.94	0	-45.3	-19.8	-30	-56.8	-19.6	0	0	0	-20.3	0	387.2	0	0	-0.6	-14	-9.2	-13	-10	-200	-56	0	-0.4	-33.2	0	0
cash-flows.row.sales-maturities-of-investments	3.07	8.2	7.9	9.1	8.6	7.5	7.2	9.2	7.9	25.6	7.9	4.4	2.6	13.5	3.5	3.6	10.5	121.1	6.6	78.4	40.9	0.8	0.9	3.1	0.6	0.1	0
cash-flows.row.other-investing-activites	15.04	-8.2	7.9	2.4	-280.2	-366.5	-6.4	83.3	-24.1	33.3	2	91.8	-386.5	1.5	2.1	-244.6	-162.3	-87.7	-91.2	-83.5	-141.2	-184	1.3	-73.8	-47.1	0	0
cash-flows.row.net-cash-used-for-investing-activites	-301.84	-313.3	-228.9	-237.7	-298	-412.9	-398.3	-168.5	-243.3	-110.2	-372.5	-246.9	-405.2	-322.5	-212.3	-240.6	-163.8	40.8	-87.4	-1.7	-299.2	-237.8	-143.9	-71.1	-79.6	-66.5	-61
cash-flows.row.debt-repayment	-572.67	-25.7	-888.7	-559.7	-729.7	-1103	-267.8	-1551.5	-1087.8	-939.7	-642.6	-756.2	-510.5	-352	-97.2	-246.7	-358.9	-331.8	-502.3	-419.6	-172	-460	-291.2	-397.9	-507.6	-233.6	-367
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-173.23	-134.9	-163	-148.4	-126.8	-116.4	-89.8	-54.4	-70.1	-86	-83.8	-70.2	-83.8	-49.4	-32.8	-32.3	-31.4	-19.6	-33	-22.5	-24.8	-27.8	-34.3	-37.8	-28.4	-23.2	-23.8
cash-flows.row.other-financing-activites	758.03	-35.5	921	568.4	891.5	1173.2	402.2	1580.7	1082.9	862.1	722.7	899.5	1071.9	529.5	176.5	356.7	439.2	260.6	325.8	284.1	360.3	504.1	313.1	858.3	437.7	300.6	414.8
cash-flows.row.net-cash-used-provided-by-financing-activities	-122.9	-196.1	-130.7	-139.7	35	-46.2	44.5	-25.2	-75	-163.5	-3.7	73.1	477.5	128.2	46.5	77.7	48.9	-90.7	-209.5	-158	163.4	16.3	-12.4	422.6	-98.3	43.8	24
cash-flows.row.effect-of-forex-changes-on-cash	12.4	6.9	15.7	-7.9	-12.3	1.3	5.8	-6.4	5.4	10.3	0.3	-11.6	-2.6	-2.8	-3.5	-1.1	-4.7	-4	-1.3	-1.6	0.6	0.7	0	0	0	0	-0.7
cash-flows.row.net-change-in-cash	88.83	-240.4	414.4	-126.2	144.9	-109.6	-3.4	189.8	126.5	85.2	-29.6	-92.7	107.6	-100.1	3.7	180.7	-16.2	66.7	-164.9	17.6	-76.1	-89.5	-113.6	337.8	-10.4	28	33.4
cash-flows.row.cash-at-end-of-period	3262.6	918.3	1010.8	596.4	722.6	577.6	679.5	682.9	493.1	366.6	281.4	282.8	375.5	268	368.1	364.4	183.7	199.8	133.1	298	337.9	414	503.5	617	279.2	289.6	261.7
cash-flows.row.cash-at-beginning-of-period	3173.78	1158.7	596.4	722.6	577.6	687.2	682.9	493.1	366.6	281.4	311	375.5	268	368.1	364.4	183.7	199.8	133.1	298	280.5	414	503.5	617	279.2	289.6	261.7	228.2
cash-flows.row.operating-cash-flow	487.09	273.4	758.2	259.1	420.2	348.3	344.6	390	439.3	348.6	346.3	92.6	37.8	97.1	173	344.8	0.1	120.6	133.3	178.9	59.1	131.3	42.7	-13.7	167.5	50.6	71.1
cash-flows.row.capital-expenditure	-321.28	-325.1	-244.8	-249.2	-280.2	-366.5	-386	-261.1	-227.1	-169.1	-260.2	-343	-386.5	-337.6	-217.9	-244.6	-162.3	-87.7	-91.2	-83.5	-141.2	-184	-146.1	-73.8	-47.1	-66.5	-61
cash-flows.row.free-cash-flow	165.81	-51.7	513.5	9.9	140	-18.2	-41.4	128.9	212.3	179.6	86.2	-250.4	-348.6	-240.5	-44.9	100.2	-162.2	32.8	42.1	95.4	-82.1	-52.7	-103.4	-87.5	120.4	-15.9	10.2

利润表行

Shandong Xinhua Pharmaceutical Company Limited 的收入与上期相比变化了 0.067%。据报告, 000756.SZ 的毛利润为 2208.45。该公司的营业费用为 1696.04，与上年相比变化了 13.530%. 折旧和摊销费用为 520.25，与上一会计期间相比变化了 -0.091%. 营业费用报告为 1696.04，显示13.530% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长0.075%. 营业收入为 512.41，与上年相比变化了0.075%. 净利润的变化率为 0.208%。去年的净收入为496.51.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
income-statement-row.row.total-revenue	7922.31	8008.7	7503	6560.1	6005.6	5606	5207.9	4515.7	4015	3597	3589.7	3169.7	2971.5	2937.5	2614.2	2321.9	2097	1887	1667.3	1696.5	1511.3	1328.5	1173.5	1099.3	1044.1	950.7	973.9	915.6	842.2	711.9	533.7
income-statement-row.row.cost-of-revenue	5715.98	5800.2	5465.7	4786.4	4191	3731.4	3649.7	3247.6	3013.6	2760.4	2854.9	2656.3	2447.2	2391.6	2133.7	1877.4	1804.2	1602.4	1371.4	1394.9	1266.7	1027.6	858.6	766.7	735	677.2	725	709.2	635.8	586.8	391.8
income-statement-row.row.gross-profit	2206.33	2208.5	2037.3	1773.7	1814.6	1874.6	1558.2	1268.1	1001.4	836.6	734.8	513.4	524.3	545.9	480.5	444.5	292.7	284.6	295.9	301.6	244.6	300.9	314.9	332.5	309.1	273.4	248.9	206.4	206.4	125.1	141.9
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	449.03	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	139.5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	718.33	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-26.24	-63.4	333.4	244.4	236.5	235.5	-12.2	-13.5	16.5	31.1	102.4	102.9	60.5	25.2	6.9	3.1	16.7	15	7.5	17.2	3.5	0.5	-0.5	0.5	-0.5	-1.5	-5.8	0.7	8.4	3.5	2.6
income-statement-row.row.operating-expenses	1663.48	1696	1493.9	1274.7	1271.7	1364.8	1142.5	942.6	790.5	687	603.8	465	471	388.9	309.3	296	226.6	227.7	259.4	275	271.1	241.4	231.3	235.9	215.5	189.3	172.4	93.5	77.6	65.8	69.4
income-statement-row.row.cost-and-expenses	7379.46	7496.3	6959.6	6061.1	5462.7	5096.1	4792.1	4190.2	3804.1	3447.4	3458.8	3121.3	2918.2	2780.4	2443	2173.5	2030.8	1830.1	1630.8	1669.9	1537.7	1269	1090	1002.7	950.5	866.6	897.4	802.7	713.5	652.6	461.1
income-statement-row.row.interest-income	13.12	12.3	10.5	8.8	6	3.6	3.7	2.9	4.7	4.2	3.3	3	3	2.4	4.8	1.9	3.6	2.3	4.7	5	5.2	6	12.3	14.7	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	38.56	41.1	49.7	53.1	59.8	55.3	54.6	52.8	63.7	83.6	74.8	68.6	56.9	28.1	19.2	19.3	18	12.2	20.4	22.4	15.4	14	13.8	18.1	9	8.6	7.7	14.2	33.9	20.8	10
income-statement-row.row.selling-and-marketing-expenses	718.33	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-1.49	18.9	-4.9	-4.4	-10.8	-6	-90.7	-57.3	-50.9	-31.9	-39.5	2.1	-18.3	-63.9	-46.1	-29.1	-20.1	-10.3	-13.5	-16.8	-27.9	-11.1	-6.2	-4.2	-10.9	-11.5	-14.8	-13.6	-29.3	-16.2	-7.7
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-26.24	-63.4	333.4	244.4	236.5	235.5	-12.2	-13.5	16.5	31.1	102.4	102.9	60.5	25.2	6.9	3.1	16.7	15	7.5	17.2	3.5	0.5	-0.5	0.5	-0.5	-1.5	-5.8	0.7	8.4	3.5	2.6
income-statement-row.row.total-operating-expenses	-1.49	18.9	-4.9	-4.4	-10.8	-6	-90.7	-57.3	-50.9	-31.9	-39.5	2.1	-18.3	-63.9	-46.1	-29.1	-20.1	-10.3	-13.5	-16.8	-27.9	-11.1	-6.2	-4.2	-10.9	-11.5	-14.8	-13.6	-29.3	-16.2	-7.7
income-statement-row.row.interest-expense	38.56	41.1	49.7	53.1	59.8	55.3	54.6	52.8	63.7	83.6	74.8	68.6	56.9	28.1	19.2	19.3	18	12.2	20.4	22.4	15.4	14	13.8	18.1	9	8.6	7.7	14.2	33.9	20.8	10
income-statement-row.row.depreciation-and-amortization	197.93	520.3	572.6	511.6	476.6	472.9	302.3	283.5	255.8	228.1	200.8	185.8	159	134.4	126.1	122.3	0.1	105.1	102.8	98	89.7	80.2	73.5	57.4	65.4	61.2	6.4	14.1	29.5	19.4	8.3
income-statement-row.row.ebitda-caps	716.06	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	518.13	512.4	476.7	425.6	422.5	387.4	337.3	281.7	147.2	92.1	54.6	-43.9	-18.7	71.9	131.7	135.9	36.4	35.5	28.1	-2.1	-51.7	52	85.9	101.6	87.1	77	70.1	98.8	99.2	40	64.3
income-statement-row.row.income-before-tax	516.64	531.3	471.8	421.2	411.6	381.4	325.1	268.2	160	117.7	91.5	50.5	35	93.2	125.1	119.4	46	46.5	29.3	12.5	-51.2	50.4	81.4	97.3	84.7	74	63	99.4	103.5	43.3	65.8
income-statement-row.row.income-tax-expense	19.18	26.6	45.5	59.2	64.5	58.3	50.8	46.9	26.9	23.7	23.2	12.2	8.7	13.6	22.4	13.4	6.4	8.4	7.6	9.8	5.3	8.4	12.6	16.3	15.5	10.4	10.2	14.9	15.1	6.4	10.2
income-statement-row.row.net-income	486.79	496.5	411.1	348.5	324.9	300	250.8	209.6	122.3	83.1	50.7	36.7	23.7	76	97.3	102.2	34	32.7	22.7	5.4	-55.6	42.1	68.8	80.9	69.1	63.6	52.8	84.5	88.4	36.9	55.6